Efficacy and safety of preoperative 5-fluorouracil, cisplatin, and mitomycin C in combination with radiotherapy in patients with resectable and borderline resectable pancreatic cancer: a long-term follow-up study
Abstract Background We aimed to evaluate the efficacy and safety of 5-fluorouracil-based neoadjuvant chemoradiotherapy (NACRT) in patients with resectable/borderline resectable pancreatic ductal adenocarcinoma (PDAC). Methods This retrospective study investigated the clinicopathological features and...
Main Authors: | Yutaka Endo, Minoru Kitago, Koichi Aiura, Masahiro Shinoda, Hiroshi Yagi, Yuta Abe, Go Oshima, Shutaro Hori, Yutaka Nakano, Osamu Itano, Junichi Fukada, Yohei Masugi, Yuko Kitagawa |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-08-01
|
Series: | World Journal of Surgical Oncology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12957-019-1687-4 |
Similar Items
-
Laparoscopic repeat liver resection after open liver resection: A comparative study from a single-centre
by: Taiga Wakabayashi, et al.
Published: (2020-01-01) -
Optimal Preoperative Multidisciplinary Treatment in Borderline Resectable Pancreatic Cancer
by: Nana Kimura, et al.
Published: (2021-12-01) -
Successful resection of pancreatic metastasis from oesophageal squamous cell carcinoma: a case report and review of the literature
by: Wataru Koizumi, et al.
Published: (2019-04-01) -
Gemcitabine/cisplatin versus 5-fluorouracil/mitomycin C chemoradiotherapy in locally advanced pancreatic cancer: a retrospective analysis of 93 patients
by: Sauer Rolf, et al.
Published: (2011-07-01) -
Total neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy and adjuvant gemcitabine for resectable and borderline resectable pancreatic cancer (PREOPANC-2 trial): study protocol for a nationwide multicenter randomized controlled trial
by: Q. P. Janssen, et al.
Published: (2021-03-01)